Severe COVID-19 can alter long-term immune response

Severe COVID-19 infection triggers changes that affect gene expression in immune system stem cells, causing alterations in the body’s immune response, according to a new study by Weill Cornell Medicine and Jackson Laboratory investigators.

Students head across globe thanks to Summer Experience Grant funding

Summer Experience Grants in the College of Arts & Sciences helped 139 students to take minimally-paid or unpaid summer positions this year. 

Around Cornell

Class of 2027 launches medical journey with white coats

Members of the Weill Cornell Medicine Class of 2027 received their short white coats on Aug. 15 during the annual White Coat Ceremony, officially marking the beginning of their medical education.

A prescription product to help people at risk

Feuerstein has founded several digital health companies and is the executive director and founder of Yale School of Medicine’s Center for Digital Health and Innovation.

Around Cornell

Technique shows how abnormal RNA splicing leads to disease

A technique that enables scientists to record gene mutations and patterns of gene activity in individual cells has been extended to cover RNA splicing as well, in a study co-led by researchers at Weill Cornell Medicine.

Scientists find ‘concerning’ flaw in malaria diagnostics

Current methods can vastly overestimate the rates that malaria parasites are multiplying in an infected person’s blood, which has important implications for determining how harmful they could be to a host, according to a new report.

Shape the future of senior living management

Heather Kolakowski, from the Cornell Institute for Healthy Futures, and industry specialists discuss sustainable and inclusive senior living in the Keynote “Affordable Senior Living: Challenges and Opportunities Ahead.”

Around Cornell

Fowell awarded NIH grant to study T cell behavior

Deborah Fowell, professor and chair of the Department of Microbiology and Immunology in the College of Veterinary Medicine, has received a five-year, $2.32 million MERIT award from the NIH to study the factors that help guide immune cells.

Gene-editing tool helps target small cancer-linked mutations

A new gene-editing tool created by Weill Cornell Medicine investigators will enable cancer researchers to study the impact of specific genetic changes in preclinical models.